VeraBank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.32M | Sell |
15,256
-254
| -2% | -$56.3K | 0.61% | 27 |
|
|
2025
Q4 | $3.54M | Sell |
15,510
-56
| -0.4% | -$12.8K | 0.64% | 24 |
|
|
2025
Q3 | $3.6M | Sell |
15,566
-131
| -0.8% | -$26.7K | 0.67% | 24 |
|
|
2025
Q2 | $2.91M | Buy |
15,697
+2,819
| +22% | +$524K | 0.58% | 26 |
|
|
2025
Q1 | $2.7M | Sell |
12,878
-50
| -0.4% | -$9.72K | 0.75% | 26 |
|
|
2024
Q4 | $2.3M | Hold |
12,928
| – | – | 0.65% | 30 |
|
|
2024
Q3 | $2.55M | Sell |
12,928
-15
| -0.1% | -$2.8K | 0.75% | 29 |
|
|
2024
Q2 | $2.22M | Hold |
12,943
| – | – | 0.69% | 31 |
|
|
2024
Q1 | $2.36M | Sell |
12,943
-159
| -1% | -$27.4K | 0.73% | 30 |
|
|
2023
Q4 | $2.03M | Buy |
13,102
+279
| +2% | +$40.7K | 0.68% | 35 |
|
|
2023
Q3 | $1.91M | Buy |
12,823
+275
| +2% | +$40.4K | 0.73% | 36 |
|
|
2023
Q2 | $1.69M | Sell |
12,548
-813
| -6% | -$119K | 0.65% | 41 |
|
|
2023
Q1 | $2.13M | Sell |
13,361
-40
| -0.3% | -$6.12K | 0.99% | 24 |
|
|
2022
Q4 | $2.17M | Buy |
13,401
+46
| +0.3% | +$7.05K | 1.08% | 24 |
|
|
2022
Q3 | $1.79M | Sell |
13,355
-164
| -1% | -$23.5K | 1.13% | 23 |
|
|
2022
Q2 | $2.07M | Buy |
13,519
+1,125
| +9% | +$172K | 1.21% | 23 |
|
|
2022
Q1 | $2.01M | Sell |
12,394
-521
| -4% | -$75.7K | 1.04% | 24 |
|
|
2021
Q4 | $1.75M | Buy |
12,915
+144
| +1% | +$17K | 0.88% | 31 |
|
|
2021
Q3 | $1.38M | Buy |
12,771
+260
| +2% | +$29.7K | 0.78% | 35 |
|
|
2021
Q2 | $1.41M | Buy |
12,511
+119
| +1% | +$13.4K | 0.84% | 33 |
|
|
2021
Q1 | $1.34M | Hold |
12,392
| – | – | 0.87% | 34 |
|
|
2020
Q4 | $1.33M | Hold |
12,392
| – | – | 0.93% | 32 |
|
|
2020
Q3 | $1.08M | Hold |
12,392
| – | – | 0.83% | 37 |
|
|
2020
Q2 | $1.22M | Hold |
12,392
| – | – | 1% | 32 |
|
|
2020
Q1 | $944K | Buy |
12,392
+1,400
| +13% | +$119K | 0.92% | 34 |
|
|
2019
Q4 | $973K | Buy |
10,992
+1,400
| +15% | +$116K | 0.79% | 37 |
|
|
2019
Q3 | $726K | Sell |
9,592
-368
| -4% | -$25.2K | 0.65% | 46 |
|
|
2019
Q2 | $724K | Sell |
9,960
-210
| -2% | -$16.5K | 0.68% | 43 |
|
|
2019
Q1 | $819K | Sell |
10,170
-100
| -1% | -$8.18K | 0.78% | 41 |
|
|
2018
Q4 | $947K | Buy |
+10,270
| New | +$903K | 1.02% | 32 |
|
Other funds holding ABBV
VCM
VPM
VeraBank's ABBV Position: Q1 2026 in Review
VeraBank reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $56.3K and leaving 15,256 shares worth $3.32M. The position accounts for 0.61% of the portfolio, ranked #27.
VeraBank first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.6M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- VeraBank held 15,256 shares of AbbVie worth $3.32M as of Q1 2026.
- VeraBank sold 254 AbbVie shares in Q1 2026, an estimated $56.3K.
- AbbVie made up 0.61% of VeraBank's portfolio in Q1 2026, its #27 holding.
- VeraBank first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
- VeraBank's AbbVie position peaked at $3.6M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on VeraBank's 13F filing for Q1 2026, filed 12 May 2026.